5 completed, 3 unknown, 2 not yet recruiting, 2 recruiting. 8 Not applicable, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 8 | Completed 3, Recruiting 2, Unknown 2, Not yet recruiting 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
Follow Cardiovascular Prevention: new trials by email Literature Review of Cardiovascular Prevention trials Research Report on Cardiovascular Prevention
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Pilot Study to Investigate Platelet Reactivity in Patients With Elevated Lipoprotein(a) and Its Response to Antiplatelet Therapy Aspirin, Clopidogrel - Cardiovascular Prevention | Not applicable | Not yet recruiting | François MACH | 60 | 2026-11-01 | 2026-07-22 |
| Randomized, Double-blind Crossover Trial Comparing Low-GI Functional vs. Standard Wholegrain Carbohydrates on Glycolipid Metabolism and Vascular Stress Markers in Adults With Suboptimal Triglyceridemia Altograno® Bakery Foods, Standard Whole-Grain Bakery Foods - Cardiovascular Prevention, Diabetes Prevention | Not applicable | Recruiting | University of Bologna | 40 | 2026-02-02 | 2026-05-01 |
| Hip Fracture Surgery Arterial and Venous Thrombotic Events Prevention rivaroxaban and ASA, Low-molecular weight heparin, Fondaparinux - Hip Fracture Surgery, Cardiovascular Prevention | Phase 3 | Not yet recruiting | McMaster University | 100 | 2025-12-01 | 2025-11-14 |
| The YOU-Fish Study: Fish and Omega 3 Supplementation in Young Adults Placebo, Dietary Supplement/Vitamins - Cardiovascular Prevention | Not applicable | Completed | University of Ulster | 40 | 2024-11-11 | 2026-07-01 |
| The Cardiovascular Prevention Program International Physical Activity Questionnaire, Six minute walking test, SF-36, Euro-Qol 5D-5L, Perceived stress scale-10, Pittsburgh Sleep Quality Index, Depression Anxiety Stress scale- 21. - Cardiovascular Prevention | Not applicable | Recruiting | Maria Cecilia Hospital | 150 | 2024-05-13 | 2024-08-28 |
| Empagliflozin and Red Blood Cell 2,3-biphosphoglycerate Levels Empagliflozin10Mg Tab - Hematocrit Change, Cardiovascular Prevention | Unknown | Aristotle University Of Thessaloniki | 40 | 2023-11-30 | 2024-02-29 | |
| New Cardiovascular Risk Screening Strategy. HELENA - Cardiovascular Prevention, Screening | Not applicable | Unknown | Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina | 54000 | 2023-11-20 | 2023-12-29 |
| Cardiac Rehabilitation for Cardiovascular Risk Reduction in People With Severe and Persistent Mental Illness Cardiac Rehabilitation Program - Mental Illness Persistent, Cardiovascular Prevention | Not applicable | Unknown | Lady Davis Institute | 46 | 2022-12-14 | 2023-03-10 |
| Implementing Shared Decision Making (SDM) For Individualized CV Prevention (SDM4IP) CV Prevention Choice Tool, Implementation Facilitation Strategies - Cardiovascular Risk, Cardiovascular Prevention | Not applicable | Completed | Mayo Clinic | 112127 | 2021-05-10 | 2026-07-29 |
| Connect2Move: Valorization of Natural Cardio Trekking Hiking Trails Measurement of cardiorespiratory performance in 3 different settings, GENERAL CARDIO HIKES AS PART OF GENERAL TOURIST OFFER OF MUNICIPALITIES - Cardiovascular Prevention, Healthy | Completed | Technical University of Munich | 144 | 2020-08-01 | 2025-01-09 | |
| Web-based Motor Intervention to Increase Health Related Physical Fitness in Children With Congenital Heart Disease Supervised web- and home-based exercise intervention - Congenital Heart Disease, Health Related Physical Fitness | Not applicable | Completed | Deutsches Herzzentrum Muenchen | 70 | 2018-06-01 | 2021-02-05 |
| Assessment of Low-dose ASA Discontinuation Risk Associated With Concomitant PPI Use During the First Year of ASA Therapy Risk of low dose aspirin discontinuation - Cardiovascular Prevention | Completed | AstraZeneca | 35604 | 2012-09-01 | 2014-05-13 |
Arteriosclerosis (1) · Bipolar Disorder (1) · Cardiovascular Diseases (1) · Heart Defects, Congenital (1) · Inflammation (1) · Motor Activity (1) · Peripheral Arterial Disease (1) · Psychotic Disorders (1) · Schizophrenia (1) · Venous Thromboembolism (1)
Cardiovascular Diseases (3) · Vascular Diseases (2) · Arterial Occlusive Diseases (1) · Atherosclerosis (1) · Behavior (1) · Bipolar and Related Disorders (1) · Cardiovascular Abnormalities (1) · Congenital Abnormalities (1) · Congenital, Hereditary, and Neonatal Diseases and Abnormalities (1) · Embolism and Thrombosis (1) · Heart Diseases (1) · Mental Disorders (1) · Mood Disorders (1) · Pathologic Processes (1) · Pathological Conditions, Signs and Symptoms (1)
Aspirin (2) · Blood Specimen Collection (1) · Carotid Intima-Media Thickness (1) · Clopidogrel (1) · Dalteparin (1) · Dietary Supplements (1) · Enoxaparin (1) · Fondaparinux (1) · N(4)-oleylcytosine arabinoside (1) · Risk (1) · Rivaroxaban (1) · Tinzaparin (1) · Vitamins (1) · apixaban (1) · empagliflozin (1)
Aristotle University Of Thessaloniki (1) · AstraZeneca (1) · Deutsches Herzzentrum Muenchen (1) · François MACH (1) · Fundacio d'Investigacio en Atencio Primaria Jordi Gol i Gurina (1) · Lady Davis Institute (1) · Maria Cecilia Hospital (1) · Mayo Clinic (1) · McMaster University (1) · Technical University of Munich (1) · University of Bologna (1) · University of Ulster (1)
Italy (3) · Canada (2) · Germany (2) · Spain (2) · Greece (1) · Switzerland (1) · United Kingdom (1) · United States (1)
Alfred Hager, MD (1) · Anna Maria Malagoni (1) · Emeir McSorley, PhD (1) · Federico Germini, Doctor of Medicine (1) · Jennifer Ridgeway, PhD (1) · Luis A Garcia Rodriguez, MD (1) · Michael J Goldfarb (1) · Rafel Ramos Blanes, MD, PhD (1) · Victor Montori, MD (1)
PMID 30211141, PMID 33516681, PMID 33883035, PMID 35830223, PMID 36554543, PMID 40520295, PMID 41082976, PMID 41827162, PMID 42218566
R01HL151662 (1)